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Abstract
Tribbles homolog 3 (TRIB3) is a scaffold protein activated under hypoxic conditions and involved in several cell survival and
proliferation pathways. Recently, we reported opposite associations of TRIB3 mRNA and protein with breast cancer
prognosis. In this study, we investigated this discrepancy between TRIB3 mRNA and protein in human breast cancer. We
provide several lines of evidence demonstrating that TRIB3 is a stabile protein which levels are not controlled by rapid
protein breakdown. Interestingly, we were able to show that during anoxia TRIB3 mRNA translation was profoundly
inhibited. Hypoxia induced micro RNA 24 was not responsible for the translational repression of TRIB3. Furthermore miRNA-
24 expression levels in breast cancer patient specimens showed no correlation with TRIB3 mRNA or TRIB3 protein levels, or
with prognosis. Thus, the expression of miRNA-24 does not explain the difference between mRNA and protein expression of
TRIB3 in this cohort of breast cancer patients. In conclusion, TRIB3 protein is a stable protein which levels are predominantly
regulated by translational control of TRIB3 mRNA transcript.
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Introduction
Tribbles homolog 3 (TRIB3) is a protein involved in multiple
signaling pathways, including MAPK [1], TGF-beta [2,3], NFkB
[4,5] and the PI3K pathway [6]. TRIB3 mRNA levels are
upregulated by a variety of stresses, including hypoxia [7]. It is
found that high TRIB3 mRNA expression is associated with a
poor prognosis in both breast cancer and colon cancer [7,8,9].
Surprisingly, in the same group of breast cancer patients we found
that TRIB3 protein expression had an opposite relation with
prognosis [9]. High TRIB3 protein expression denotes a good
prognosis. In oral tongue squamous cell carcinomas it was also
found that TRIB3 protein expression was associated with a good
prognosis [10].
These results spurred us to further investigate the control
mechanisms responsible for TRIB3 protein expression. It is a
general assumption that a gene is transcribed into mRNA, which is
then directly translated into protein. The amount of transcribed
mRNA thereby –at least partly- reflects the final amount of
protein. Much of the mechanistic conclusions drawn from
expression profiling studies in, for example, breast cancer are
based on this premise. During the last decades, however, it has
become clear that there are multiple ways to control protein levels,
and that TRIB3 is a protein that might be tightly regulated on
several levels.
Rzymski et al. showed that after anoxic exposure TRIB3 protein
levels are increased at earlier time points than mRNA upregula-
tion [4], suggesting rapid regulation of TRIB3 protein levels under
hypoxia. Further, Ohoka et al. described that TRIB3 is an unstable
protein that is ubiquitinated by cdh1 and thereby tagged for
proteasomal degradation [11], a degradational process that plays
an important role in protein level regulation. Hu-antigen R (HuR)
also contributes to the increased expression of TRIB3 protein
through increased translation and transcript stability under anoxia
[4]. HuR is believed to bind to AU-rich elements in mRNAs and
thereby it regulates both the stability and cytoplasmic/nuclear
localization of mRNAs. One of the mechanisms potentially
responsible for the discordance between TRIB3 mRNA and
protein levels could be through expression of a class of small non-
coding RNAs called microRNAs (miRNAs). miRNAs play an
important role under both physiological and pathological condi-
tions. Long pre-cursor miRNA called pri-miRNA are transcribed
from the genome and are subsequently processed by the
ribonucleases Drosha and Dicer into 21–24 nucleotide mature.
In mammalian cells these mature miRNAs mostly hybridize
imperfectly to the 39UTR of target mRNAs and either cause
mRNA instability or suppression of their translation. Due to the
imperfect homology miRNAs can regulate multiple mRNA
targets. It is estimated that all known miRNAs regulate up to
30% of the genes in the human genome [12,13]. So far the only
experimentally validated miRNA that targets TRIB3 is miRNA-
24 (miRWalk [3,14]). This miRNA is upregulated during hypoxia
[3,15], and is interestingly involved in similar signaling pathways
as TRIB3 itself namely TGF-beta [3,16,17,18] and MAPK
signaling [19]. Furthermore it plays a role in cell cycle regulation
[20,21] and is frequently de-regulated in tumor cells [21].
Therefore, we hypothesized that miRNA-24 could be involved
in TRIB3 mRNA translational regulation during hypoxia.
Here, we investigated the discrepancy between TRIB3 mRNA
and TRIB3 protein levels. For this we analyzed protein
degradation and mRNA translation rates of TRIB3 in breast
cancer cell lines under normoxic and hypoxic conditions.
Furthermore, we used a patient cohort to investigate if miRNA-
24 could mediate translational inhibition of TRIB3 mRNA, and
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whether the level of miRNA-24 itself has prognostic value in breast
cancer.
Materials and Methods
Ethics statement
As approved by the Radboud University Nijmegen Medical
Centre Institutional Review Board and according to the ‘‘Code
Proper Secondary Use of Human Tissue’’ developed by the
Federation of Medical Societies (FMWV) in the Netherlands and
Dutch national law, coded tumor tissues from anonymized
patients were used. This study was performed according to
REMARK guidelines [22].
Patient samples
Frozen breast cancer tissue sections were available from in total
94 patients who had undergone resection of their primary tumor.
The patient cohort is as described before with one failure due to
missing miRNA 24 value [9]. Breast cancer patients were selected
from a cohort treated between January 1991 and December 1996,
that were not treated systemically, and had at least 5 years follow
up or a recurrence before that. The selection criteria resulted in a
patient cohort with 25% ER positive, 13% PR positive, 30%
HER2-positive, and 44% triple negative patients.
Breast cancer cell lines
Human breast cancer cells MDA-MB-231 and MCF-7 (ATCC,
LGC Promochem, London, UK) were cultured for a limited
number of passages in standard culture medium (DMEM with
10% dialyzed FCS, 2 mM L-glutamine, 20 mM HEPES, penicil-
lin/streptomycin, and nonessential amino acids (all PAA Labora-
tories, Pasching, Austria)) at 37uC with 5% CO2, unless stated
otherwise.
Knockdown of TRIB3 was performed using siRNA transfection
reagent SAINT-RED (Synvolux Therapeutics B.V., Groningen,
the Netherlands). siRNA’s MISSIONH siRNA Universal Negative
Control #1 (SIC001) and TRIB3 (SASI_Hs01_00197511) were
acquired from Sigma-Aldrich (Sigma-Aldrich Chemie B.V.,
Zwijndrecht, the Netherlands). After transfection siRNA’s were
giving 24 hours to reduce TRIB3 mRNA levels and thereafter
treated for 24 to 48 hours before harvesting of the cells.
For incubation under hypoxic conditions a hypoxic culture
chamber was applied (H35 hypoxystation, Don Whitley Scientific,
West Yorkshire, UK). Treatment of cells was performed with 1 or
10 mM of the proteasome inhibitor MG132 (Calbiochem, La Jolla,
CA, USA), 50 mM chloroquine disphosphate salt (CQ, Sigma-
Aldrich Chemie BV, Zwijndrecht, the Netherlands) and 100 mg/
ml cycloheximide (CHX, Sigma-Aldrich Chemie BV). In the
experiments where we combined treatment with hypoxia exposure
compounds were added immediately before the cells were
transferred into the hypoxic culture chamber.
Western blot analysis
Cells were harvested in RIPA buffer (PBS (Klinipath, Duiven,
the Netherlands), MQ (Sterile H2O, VersolH, Lyon, France), NP-
40 (Sigma-Aldrich Chemie BV), Sodiumdesoxycholate (VWR
International BV, Amsterdam, the Netherlands) and SDS) with
phosphatase and protease inhibitors (Roche, Indianapolis, IN,
USA). Samples were sonicated, centrifuged and supernatant was
stored at 280uC. Protein quantification was performed using a
PierceH BCA Protein Assay Kit (Thermo Scientific, Etten-Leur,
the Netherlands). Thirty microgram of protein was fractionated on
4–20% Criterion XT Bis-Tris gels (Bio-Rad Laboratories BV).
After electrophoresis, samples were transferred to PVDF mem-
branes (Millipore Immobilon, Millipore BV, Amsterdam, the
Netherlands). Membranes were blocked with 5% NFDM (Blotting
Grade Blocker Non-Fat Dry Milk, Bio-Rad Laboratories BV) and
incubated with the appropriate antibodies (mouse anti-a-tubulin
(1:1000, Cell Signaling Technology, BIOKE´, Leiden, the Nether-
lands) rabbit anti-b-catenin (1:1000, Cell Signaling Technology) or
chicken anti-TRIB3 peptide 3 (1:500, characterized in [9])).
Proteins were detected using chemiluminescent peroxidase sub-
strate (Sigma-Aldrich Chemie BV) and visualized with a
ChemiDoc XRS+imaging system (Bio-Rad Laboratories BV).
Images and protein band intensities were acquired using Quantity
OneH 1-D Analysis Software (Bio-Rad Laboratories BV). Signal
intensities were quantified using gel analyze tools from Image J
[23] and corrected for a-tubulin intensities detected on the same
blot.
Polysomal Fractionation and Analysis
Polysomal fractionation and analysis was performed as
described previously [24].
Cells were treated with 0.1 mg/ml cycloheximide (CHX) for
3 min at 37uC, washed twice with ice cold PBS/CHX and
harvested by scraping in lysis buffer (1% Triton X-100, 0.3 M
NaCl, 15 mM MgCl2, 15 mM Tris (pH 7.4), 0.1 mg/ml CHX,
100 units RNAse-In (Ambion)) at 4uC. Nuclei were removed and
residual debris was removed by centrifugation. The lysate was
layered on a10 ml continuous sucrose gradient (20–50% sucrose in
15 mMMgCl2, 15 mM Tris (pH 7.4), 0.3 M NaCl). After 90 min
of centrifugation at 260,000 g at 4uC, the absorbance at 254 nm
was measured continuously as a function of gradient depth in a
BioRad Laboratories UV monitor. Translation efficiency was
defined as the sum of the relative TRIB3 mRNA expression
multiplied by the average number of ribosomes within each
fraction divided by the total amount of TRIB3 mRNA.
miRNA measurement
Total RNA from frozen tissue sections or cell cultures was
isolated with the total RNA purification kit (Norgen Biotek Corp.,
Ontario, Canada). For the tissue sections an adjacent H&E stained
section was used to determine the percentage of tumor cells in the
tissue. Reverse transcriptase reaction was performed with
NCodeTM VILOTM miRNA cDNA Synthesis Kit (Invitrogen,
Carlsbad, CA, USA) and miRNA expression was determined
using Sybr Green Master Mix (Applied Biosystems, Nieuwerkerk
a/d lJssel, the Netherlands) with miRNA-24 forward primer
(gctcagttcagcaggaac) or RNU6 forward primer (cgcaaggatgacacg-
caaattc, both Biolegio BV, Nijmegen, the Netherlands) and
Universal qPCR primer (Invitrogen) on an CFX96 realtime
PCR detection system (Bio-Rad Laboratories BV, Veenendaal, the
Netherlands). All samples were normalized for levels of RNU6
expression.
Statistical analyses
Statistical analyses were carried out using SPSS 16.0.5 software
(SPSS Benelux BV, Gorinchem, the Netherlands). Normality of
distribution of variables was tested using Kolmogorov-Smirnov
testing. Differences were assessed with parametric unpaired t-tests
and bonferroni’s multiple comparison test or non-parametric
Mann-Whitney U tests (for two groups) or with Kruskall-Wallis
tests (for more than two groups) where appropriate. Non-
parametric correlations were established using Spearman Rank
correlation testing. Disease free survival (DFS) time (defined as the
time from surgery until diagnosis of recurrent or metastatic
disease) and overall survival (OS) time (defined as the time
Regulation of TRIB3
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between date of surgery and death by any cause) were used as
follow-up endpoints. Survival curves were generated using the
method of Kaplan and Meier, after patients were categorized by
miRNA-24 expression in either two or three equally sized groups,
thus either at the p50, or at the p33 and p66. Equality of survival
distributions was tested using log-rank testing, with Mantel-Cox
test for trend when more than two groups were analyzed. Two-
sided P-values below .05 were considered to be statistically
significant.
Results
TRIB3 knockdown does not affect TRIB3 protein
expression
During our studies to investigate the biological relevance of
TRIB3 for the adaptation to hypoxic conditions we developed a
TRIB3 knockdown model. This siRNA approach was successful in
decreasing TRIB3 mRNA levels compared to cells treated with
negative control siRNA (SCR) during normoxia and hypoxia
(P=,.001) (Figure 1A). Even though the mRNA levels were
profoundly reduced by the siRNA mediated knockdown the
protein levels did not diminish in these cells neither under
normoxic nor hypoxic conditions (P= .80) (Figure 1B). This data
suggests that TRIB3 is a very stable protein.
TRIB3 protein degradation
To determine the rate of protein degradation through the
proteasome we treated breast cancer cells with the proteasome
inhibitor MG132. MDA-MB-231 cells were exposed to 0, 2, 6, or
16 hours of hypoxia (0.1% oxygen) and treated with MG132. In
the cell-lysates from these cells we determined protein concentra-
tions of b-catenin, TRIB3 and a-tubulin using western blotting
(Figure 2A). b-catenin protein expression was used as a positive
control to confirmed the effect of MG132 on proteasomal
degradation. This protein was clearly more abundant in all
samples treated with MG132, confirming the inhibition of
proteosomal degradation in these samples. However, TRIB3
protein levels did not change after treatment with MG132 nor
after exposure to hypoxia, indicating that TRIB3 is not degraded
by the proteasome. Thus, proteosomal degradation is not involved
in the apparent strict regulation of TRIB3 protein levels in breast
cancer cells.
Next we assessed whether TRIB3 protein levels might be
affected through the autophagic pathway. Chloroquine (CQ) was
used to block autophagy allowing us to measure the autophagic
flux in MDA-MB-231 cells that were culture under normoxic or
hypoxic (1% oxygen) conditions for 2, 6, 16 or 24 hours.
Treatment with CQ under normal conditions resulted in an
increased accumulation of LC3bI and II consisted with a blocked
autophagic pathway (Figure 2B). Under hypoxic conditions the
LC3BII form accumulates indicating a high flux through the
autophagic pathway and thus more active autophagy. Blocking
autophagy however did not lead to an increase in TRIB3 protein
expression. This data rules out autophagy as a potential regulator
of TRIB3 protein levels.
The protein stability of TRIB3
Since in our hands neither inhibiting the proteasome nor
inhibiting the autophagy pathway seems to effect TRIB3 protein
expression in MDA-MB-231 cells the stability of the protein was
determined using a translational inhibitor cycloheximide (CHX).
To test whether the TRIB3 breakdown rate is cell line dependent
we used MDA-MB-231 as well as MCF-7 cells. Cells were exposed
to CHX during normoxic or hypoxic (1% oxygen) conditions for
2, 6, 24 or 48 hours. HIF-1 expression was used as a positive
control for the translational inhibition. During normoxic condi-
tions HIF-1 protein was barely detectable using western blotting in
both cell lines (Figure 2 C and D), consisted with the extremely
short half-life of HIF-1 under aerobic conditions. As expected
hypoxic conditions results in remarkably higher HIF-1 protein
levels due to the inhibition of oxygen dependent degradation of
HIF-1. Translational inhibition reduced HIF-1 levels during
normoxia and this effect was more obvious during hypoxia. In
the MDA-MB-231 cells TRIB3 protein levels did not change as a
result of translational inhibition. For MCF-7 cells an increase is
seen in TRIB3 levels both during normoxia and hypoxia when
treated with CHX for 2 and 6 hours. A decrease in TRIB3 levels is
seen in the MCF-7 cells treated with CHX for 48 hours, however
Figure 1. Effect of siRNA mediated knockdown of TRIB3 on mRNA and protein levels. A. Fold induction of TRIB3 mRNA in MDA-MB-231
cells during normoxia and after 24 hours of hypoxia (1% oxygen) treated with negative control siRNA (SCR) or siRNA mediated TRIB3 knockdown
(TRIB3-KD) (n = 8). B. Fold induction of TRIB3 protein intensity in MDA-MB-231 cells during normoxia or after 24 hours of hypoxia (1% oxygen) treated
with negative control siRNA (SCR) or siRNA mediated TRIB3 knockdown (TRIB3-KD) (n = 3). Protein intensities were controlled for a-tubulin intensities
on same blot. Fold induction are averages (+ SD) relative to levels in cells treated with control siRNA (SCR) during normoxia.
doi:10.1371/journal.pone.0049439.g001
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this decrease is also observed for a-tubulin. CHX treatment for
48 hours was toxic to the cells and the reduction in the number of
cells used for protein extraction led to a lower protein amount
loaded on the gel. These results show that TRIB3 is a relative
stable protein with half lives comparable to a-tubulin under both
normoxia and hypoxia.
TRIB3 mRNA translation is reduced by anoxic exposure
To further investigate the discrepancy between TRIB3 overall
mRNA and protein levels we measured TRIB3 mRNA translation
upon anoxia. RNA isolated from MCF7 cells was separated
through sucrose gradients based on the number of ribosomes
associated with the RNA. Exposure to anoxic conditions for 24 hrs
caused an inhibition of general translation (Figure 3A). TRIB3
mRNA levels were ,5-fold up regulated in MCF7 cells upon
anoxia (P= .035, Figure 3B). Nevertheless anoxia caused a change
in the distribution of the TRIB3 mRNA within the polysome.
More TRIB3 mRNA was detected within the fractions containing
less ribosomes (fractions L+M) compared to aerobic conditions
where most of the TRIB3 mRNA is associated with many
ribosomes (H fraction) (Figure 3C). As the number of polysomes
on the RNA reflects the extent of translation into protein, these
results indicate that anoxia inhibits the translation of TRIB3
mRNA into protein. Finally, we calculated the translation
efficiency for TRIB3 as described in the material and methods.
Consistent with the tendency of TRIB3 mRNA to be associated
with less ribosomes, the translation efficiency is profoundly
reduced under anoxic conditions (P= .0399, Figure 3D). This
Figure 2. Effect of proteasome inhibition on TRIB3 protein levels. A. Western blot of MDA-MB-231 cells treated with MG132 and exposed to
hypoxia (0.1% oxygen) immunostained for b-catenin (positive MG132 control), TRIB3 and a-tubulin (loading control). B. MDA-MB-231 cells treated
with hydroxychloroquine (CQ) and exposed to hypoxia (1% oxygen) immunostained for LC3b (positive autophagy inhibition marker), TRIB3 and a-
tubulin (loading control). C. MDA-MB-231 cells treated with cycloheximide (CHX) and exposed to hypoxia (1% oxygen) immunostained for HIF-1
(positive translation inhibition control), TRIB3 and a-tubulin (loading control). D. MCF-7 cells treated with cycloheximide (CHX) and exposed to
hypoxia (1% oxygen) immunostained for HIF-1 (positive translation inhibition control), TRIB3 and a-tubulin (loading control).
doi:10.1371/journal.pone.0049439.g002
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data suggest that translational control of TRIB3 mRNA can
explain discrepancies between TRIB3 mRNA abundance and
protein levels, especially under oxygen deprived conditions.
miRNA-24 expression in breast cancer cells during
hypoxia
Repression of TRIB3 mRNA translation could potentially be
mediated through hypoxia induced miRNAs. Analysis of the
39UTR of TRIB3 using the prediction algorithm TargetScan
revealed miRNA24 as a potential candidate [13,25]. First we
determined whether hypoxia indeed upregulates miRNA-24 levels
in breast cancer cells during hypoxia. For this we quantified
miRNA-24 expression in MDA-MB-231 breast cancer cells
exposed for 24 hours to 0.5%, 0.2%, or 0.1% oxygen. Hypoxia
indeed caused an induction in miRNA-24 expression ranging from
2.4 to 6.5 fold (P=0.029). The strongest induction was observed in
the cells exposed to the lowest oxygen concentration (Figure 4).
Thus, miRNA-24 is a potential candidate marker that could
explain the opposite association of TRIB3 mRNA and protein
with breast cancer prognosis.
miRNA-24 expression in breast cancer patients
Next, we assessed whether an inverse correlation exists between
miRNA-24 and TRIB3 mRNA or protein levels in breast cancer
patients. miRNA-24 expression was detectable in all 94 available
breast tumor samples. The miRNA-24 levels were not log-
normally distributed and therefore non-parametric statistical tests
were used. TRIB3 mRNA and protein expression were deter-
mined and scored as described before [9]. There was no
correlation between miRNA-24 levels and mRNA (rs =2.091,
P= .383) or protein (rs = .009, P= .932) levels of TRIB3 (Table 1).
Figure 3. TRIB3 mRNA translation during anoxia. A. Polysome profiles of MCF7 cells grown under aerobic of anoxic conditions during 24 hours.
B. TRIB3 mRNA levels determined by Q-PCR in the total RNA fraction. C. TRIB3 mRNA distribution within the polysome. D. Change in translation
efficiency of the TRIB3 mRNA after exposure to anoxia for 24 hrs. Experiments were performed in triplicates.
doi:10.1371/journal.pone.0049439.g003
Figure 4. miRNA-24 expression after hypoxia. Expression levels
(average +/2 SD, n = 4) measured by RT-qPCR of miRNA-24 controlled
for RNU6 expression in MDA-MB-231 cells exposed to 0.5%, 0.2% or
0.1% oxygen during 24 hours.
doi:10.1371/journal.pone.0049439.g004
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Next, patients were divided into 6 groups based on low or high
TRIB3 mRNA expression and negative, weak or strong TRIB3
protein expression. There was no difference in miRNA-24
expression between these groups (P= .7, Table 2), indicating that
miRNA-24 could not explain the discrepancy in TRIB3 mRNA
and protein levels in these patients.
Finally, we determined whether miRNA-24 expression on its
own has any clinical value. miRNA-24 expression levels exhibited
no association with any clinicopathological characteristic tested
besides histological grade (grade I/II vs. III, 0.610 vs 0.910 median
miRNA expression *1023, P= .02) (Table 3). Furthermore,
miRNA-24 did not show a relation with DFS or OS when the
patient group was split according to expression levels into 2 groups
at the median (P= .83 and P= .93) or into 3 groups at 33% and
66% (P= .73 and P= .96) (Figure 5).
Discussion
Recently it has been described that patients with tumors that
express more TRIB3 mRNA exhibit a poor prognosis [7,8,9],
whereas in patients tumors with high levels of TRIB3 protein as
established by immunohistochemistry were associated with a good
prognosis [9,10]. TRIB3 protein expression is most likely related
to function and it is, therefore, that TRIB3 is probably functionally
associated with a good prognosis. Indeed, previously TRIB3 has
been found to be involved in ER stress induced cell death
[26,27,28]. The important role for TRIB3 in cell survival under
hypoxic conditions was indicated by the observation that after
knockdown of TRIB3 cell survival was increased under hypoxia
[9]. Thus, the relation of TRIB3 protein with a good prognosis in
breast cancer patients could be due to its role in hypoxia-induced
cell death. Tumors that are more hypoxia sensitive are less
aggressive and respond better to for instance radiotherapy [29,30].
On the other hand, the finding that high TRIB3 mRNA is
associated with a poor prognosis suggests that any mechanism that
is involved in the induction of TRIB3 mRNA is also involved in
tumor progression and/or treatment resistance. Data supports that
the CHOP/ATF4 arm of the unfolded protein response (UPR)
which is responsible for TRIB3 upregulation during hypoxia [7]
protects tumor cells during hypoxia [31].
The discrepancies between TRIB3 mRNA and protein and
their opposing relation with breast cancer prognosis spurred us to
investigate the regulatory mechanisms involved in TRIB3
translation. siRNA mediated knockdown of TRIB3 mRNA had
no effect on TRIB3 protein levels in breast cancer cells. Further,
inhibition of proteasomal degradation or autophagy had no
appreciable effect on TRIB3 protein levels during normoxia or
hypoxia and inhibition of translation indicated TRIB3 to be a
stable protein. The upregulated of TRIB3 levels after inhibition of
translation that was observed could be due to an effect on a
protein that is involved in TRIB3 protein regulation. We could
confirm that the only so far known TRIB3 specific micro RNA
(miRNA-24) was upregulated during hypoxia in breast cancer
cells. However, miRNA-24 levels did not correlate with either
mRNA or protein expression of TRIB3 in breast cancer patients.
While miRNA-24 has previously been described as a cell type-
specific oncogene and tumor suppressor [21,32,33,34] we did not
find any prognostic value for miRNA-24. Martin et al. suggest that
the passenger strand miR-24-2*, which does not bind TRIB3,
might be involved in the opposing oncogenic and tumor
suppressive roles of miRNA-24 [35].
TRIB3 mRNA is induced by hypoxia and ER stress via the
PERK/ATF4/CHOP arm of the unfolded protein response
(UPR) [7,26,36]. In addition, the NFkB pathway regulates TRIB3
expression after anoxia and Hu-antigen R (HuR) stabilizes the
mRNA of TRIB3 [4]. Other pathways in which TRIB3 is involved
are the MAPK [1], TGF-beta [2,3] and PI3K pathway
[6,37,38,39]. Interestingly, TRIB3 reportedly constitutes a feed-
back loop with almost all of these pathways [1,2,4,6,27,40,41].
The combination of all these pathways and multiple feedback
loops contributes to a tight regulatory control of TRIB3
emphasizing the importance of TRIB3 protein function. TRIB3
is involved in regulating multiple pathways in cell survival and
could thereby affect cell survival and cancer prognosis. Under-
standing TRIB3 protein regulation mechanisms in more detail
could provide valuable information for means to regulate cancer
cell survival.
Rzymski et al. explored regulation mechanisms that could
contribute to the control of TRIB3 [4]. They determined that the
anoxia-induced upregulation of TRIB3 protein is faster than, and
therefore probably not dependent on, TRIB3 mRNA upregulation
[4]. Their focus was mainly on the regulation of mRNA levels
rather than on protein levels. Here we studied mechanisms that
effect protein regulation, as we found that attenuating TRIB3
mRNA levels using siRNA had no effect on TRIB3 protein levels.
TRIB3 protein has been described to be tightly regulated by
proteasomal degradation via ubiquitination by cdh1 [11,42]. An
unstable protein is for its stimulation more dependent on the
degradation rate than on the mRNA expression as protein levels
could increase quickly when protein degradation is diminished
without increasing levels of mRNA. This could explain the more
rapid increase of TRIB3 protein compared to mRNA under
anoxic conditions [4]. We could not find any effect of inhibiting
Table 1. Correlation between miRNA-24 expression and
TRIB3 mRNA and protein expression.
TRIB3 mRNA TRIB3 protein
miRNA-24 Correlation Coefficienta 2.091 .009
P .383 .932
n 94 94
TRIB3 protein Correlation Coefficienta 2.043
P .683
N 94
aSpearman’s rho.
doi:10.1371/journal.pone.0049439.t001
Table 2. miRNA 24 expression levels in groups with
accordance and discordance between TRIB3 mRNA and
protein.
TRIB3 protein score negative weak Strong
TRIB3 mRNA
,median n 14 27 6
median miRNA24/RNU6 (*1023) 0.8 0.89 0.9
interquartile range miRNA24/
RNU6 (*1023)
1.49 1.43 0.99
.median n 17 24 6
median miRNA24/RNU6 (*1023) 0.88 0.6 1.15
interquartile range miRNA24/
RNU6 (*1023)
1.34 1.16 0.9
doi:10.1371/journal.pone.0049439.t002
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proteasomal degradation on the TRIB3 protein levels in breast
cancer cells both during normoxia and hypoxia. The UPR has also
been described to play a role in the activation of the autophagy
pathway, which can also degrade proteins. Inhibiting autophagy
did also not affect TRIB3 protein levels. Therefore, we wondered
whether TRIB3 protein was in breast cancer cells as unstable as
suggested before [4]. In fact, inhibiting the translation showed that
TRIB3 protein is stable throughout 48 hours under both
normoxic and hypoxic conditions. Being a stable protein both
under normoxic and hypoxic conditions the discrepancies between
mRNA and protein are more likely to arise in the translational step
between them. Our observation that TRIB3 mRNA translation is
reduced under anoxic conditions even though mRNA levels are
increased further strengthens this hypothesis. One possible
explanation could be that activation of the UPR leads to an
upregulation of TRIB3 mRNA but also results in general
translational inhibition [24]. However, a negative feedback loop
via GADD34 leads to the dephoshorylation of eIF2a and thereby
might promote recovery from this translational inhibition [43].
miRNAs are also capable of inhibiting translation of the mRNA
transcript. Thus, TRIB3 specific miRNAs such as miRNA-24
(miRWalk, [3,14]) might attenuate TRIB3 protein levels even in
the presence of high mRNA levels. We found that miRNA-24 is
hypoxia regulated in breast cancer cells, which is in line with what
has been reported for other cell types [3,15]. The exact oxygen
tension might be of relevance for TRIB3 protein regulation.
TRIB3 mRNA levels increase at both 0.1 and 1% oxygen,
whereas TRIB3 protein only increases at 1% oxygen. As we found,
this is not caused by increased degradation via the proteasome at
0.1% oxygen. Possibly, the induction of miRNA-24 at 0.1%
oxygen precludes TRIB3 mRNA from being translated to TRIB3
protein. However, we did not find a relation between miRNA-24
and TRIB3 protein or mRNA. Although miRNA-24 was the
miRNA with the lowest p-value (,.001) of the 9 predicted
miRNA’s for TRIB3 (miRWalk, [14]), it could well be that other
miRNAs are responsible for the discrepancies found.
In conclusion, we showed that TRIB3 is a stable protein and
that translational control is most likely responsible for the
discrepancies between TRIB3 mRNA and protein. Further
research is needed to understand the mechanisms through which
TRIB3 is translationally regulated in more detail.
Table 3. Associations of miRNA-24 expression levels with clinicopathological characteristics.
Variable N=94a
Median
(*1023 miRNA-24/RNU6)
Interquartile range
(*1023 miRNA-24/RNU6) Pb
Age (years)
,50 28 0.755 0.75 0.38
$50 64 0.915 1.40
Menopausal status
Premenopausal 26 0.795 0.87 0.58
Postmenopausal 68 0.890 1.41
Tumor type
Ductal 75 0.840 0.99 0.87
Lobular 8 1.060 1.84
Other (mixed/unknown) 11 0.940 1.19
Tumor size
pT1 49 0.870 0.98 1.00
pT2 40 0.840 1.41
pT3/4 4 0.875 1.18
Histological grade
I/II 22 0.610 0.75 0.02
III 53 0.910 1.32
Estrogen Receptor
negative 65 0.880 1.02 0.69
positive 27 0.710 1.16
Progestrone Receptor
negative 77 0.890 1.38 0.40
positive 15 0.670 0.67
Human Epidermal Growth Factor Receptor 2
negative 67 0.830 1.36 0.90
positive 25 0.890 0.92
aDue to missing values, numbers do not always add up to 94.
bP tested with Mann-Whitney U test or Kruskal-Wallis Test where appropriate.
doi:10.1371/journal.pone.0049439.t003
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